EVALRIVE Trademark

Trademark Overview

On Tuesday, January 5, 2016, a trademark application was filed for EVALRIVE with the United States Patent and Trademark Office. The USPTO has given the EVALRIVE trademark a serial number of 86865832. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2019. This trademark is owned by GENENTECH, INC.. The EVALRIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical oncology preparation, namely, pharmaceutical products for the prevention or treatment of cancer
evalrive

General Information

Serial Number86865832
Word MarkEVALRIVE
Filing DateTuesday, January 5, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements

Goods and ServicesPharmaceutical oncology preparation, namely, pharmaceutical products for the prevention or treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 13, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Trademark Events

Event DateEvent Description
Monday, August 5, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 5, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 13, 2018EXTENSION 5 GRANTED
Monday, November 5, 2018EXTENSION 5 FILED
Tuesday, November 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 5, 2018TEAS EXTENSION RECEIVED
Saturday, May 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2018EXTENSION 4 GRANTED
Thursday, May 24, 2018EXTENSION 4 FILED
Thursday, May 24, 2018TEAS EXTENSION RECEIVED
Saturday, November 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2017EXTENSION 3 GRANTED
Thursday, November 9, 2017EXTENSION 3 FILED
Thursday, November 9, 2017TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 19, 2017EXTENSION 2 GRANTED
Monday, June 19, 2017EXTENSION 2 FILED
Monday, June 19, 2017TEAS EXTENSION RECEIVED
Tuesday, January 17, 2017ASSIGNED TO EXAMINER
Thursday, January 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2017EXTENSION 1 GRANTED
Tuesday, January 3, 2017EXTENSION 1 FILED
Tuesday, January 3, 2017TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 27, 2016ASSIGNED TO EXAMINER
Wednesday, January 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 8, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

evalrive pharmaceutical treatment cancer prevention namely oncology preparation products